Dr Laitman discusses evidence supporting the reclassification of schizophrenia as a neurological disorder, his views on how reclassification could impact prognosis and recovery, and treatment interventions...
Jacob Miguel Vigil, PhD, discusses new study findings that suggest THC may confer more therapeutic benefit than CBD across many different health conditions, and why he says now is the “Golden Age” of...
Leonard Calabrese, DO, highlights important topics that will be covered at the Interdisciplinary Autoimmune Summit (IAS) and how the meeting addresses the intersection between immune diseases in...
Dr David Nash, founding dean of the Jefferson College of Population Health, discusses the patient- and physician-level impact of rising pharmaceutical prices, and outlines steps he says are needed to truly...
In this 3-minute mini-podcast, Dr James Matera from CentraState Medical Center discusses how the 2017 ACC/AHA hypertension guideline has changed the landscape when it comes to managing comorbid...
In the final installment of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA discusses suicidality in patients with schizophrenia compared with the general...
In part 3 of his podcast series with Consultant360, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA explains the importance of treating his patients’ physical and societal health in...
Schizophrenia is not a death sentence, says Robert S Laitman, MD, from Bronx Westchester Medical Group and SARDAA. In part 2 of his podcast series with Consultant360, Dr Laitman explains how his approach to...
Michael S. Barr, MD, and Patricia Barrett from the National Committee for Quality Assurance discuss Patient-Centered Home Care for the primary care provider.
